Feith, Marcus

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 17.

Journal Article

Buck, Achim; Prade, Verena M; Kunzke, Thomas; Feuchtinger, Annette; Kröll, Dino; Feith, Marcus; Dislich, Bastian; Balluff, Benjamin; Langer, Rupert; Walch, Axel (2022). Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients. The journal of pathology, 256(2), pp. 202-213. Wiley 10.1002/path.5828

Galván, José A.; Wiprächtiger, Julia; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Kröll, Dino; Seiler, Christian A.; Langer, Rupert (2020). Immunohistochemical analysis of the expression of cancer-associated fibroblast markers in esophageal cancer with and without neoadjuvant therapy. Virchows Archiv, 476(5), pp. 725-734. Springer 10.1007/s00428-019-02714-6

Osecky, Marek Michal; Kröll, Dino; Feith, Marcus; Reim, Daniel; Dislich, Bastian; Becker, Karen; Langer, Rupert (2020). Tumor Regression in Lymph Node Metastases of Esophageal Adenocarcinomas after Neoadjuvant Therapy. Gastrointestinal disorders, 2(4), pp. 397-407. MDPI 10.3390/gidisord2040036

Adams, Olivia; Janser, Félice A.; Dislich, Bastian; Berezowska, Sabina; Humbert, Magali; Seiler, Christian A.; Kröll, Dino; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Tschan, Mario P.; Langer, Rupert (2019). Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS ONE, 14(10), e0224832. Public Library of Science 10.1371/journal.pone.0224832

Adams, Olivia; Janser, Félice A.; Dislich, Bastian; Berezowska, Sabina; Humbert, Magali; Seiler, Christian A.; Kroell, Dino; Slotta-Huspenina, Julia; Feith, Marcus; Ott, Katja; Tschan, Mario P.; Langer, Rupert (2018). A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS ONE, 13(6), e0197610. Public Library of Science 10.1371/journal.pone.0197610

Slotta-Huspenina, Julia; Drecoll, Enken; Feith, Marcus; Habermehl, Daniel; Combs, Stephanie; Weichert, Wilko; Bettstetter, Marcus; Becker, Karen; Langer, Rupert (2018). MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus. Journal of translational medicine, 16(1), p. 109. BioMed Central 10.1186/s12967-018-1492-9

Thies, Svenja; Guldener, Lars; Slotta-Huspenina, Julia; Zlobec, Inti; Kölzer, Viktor; Lugli, Alessandro; Kröll, Dino; Seiler, Christian A.; Feith, Marcus; Langer, Rupert (2016). Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas. Human pathology, 52, pp. 1-8. Elsevier 10.1016/j.humpath.2016.01.016

Karamitopoulou, Evanthia; Thies, Svenja; Zlobec, Inti; Ott, Katja; Feith, Marcus; Slotta-Huspenina, Julia; Lordick, Florian; Becker, Karen; Langer, Rupert (2014). Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches. The American journal of surgical pathology, 38(11), pp. 1551-1556. Lippincott Williams & Wilkins 10.1097/PAS.0000000000000255

Liebl, Florian; Demir, Ihsan Ekin; Mayer, Katharina; Schuster, Tibor; DʼHaese, Jan G; Becker, Karen; Langer, Rupert; Bergmann, Frank; Wang, Kun; Rosenberg, Robert; Novotny, Alexander R; Feith, Marcus; Reim, Daniel; Friess, Helmut; Ceyhan, Güralp O (2014). The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study. Annals of surgery, 260(5), pp. 900-907. Lippincott Williams & Wilkins 10.1097/SLA.0000000000000968

Aichler, Michaela; Motschmann, Martin; Jütting, Uta; Luber, Birgit; Becker, Karen; Ott, Katja; Lordick, Florian; Langer, Rupert; Feith, Marcus; Siewert, Jörg Rüdiger; Walch, Axel (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. OncoTarget, 5(16), pp. 6620-6632. Impact Journals LLC

Langer, Rupert; Becker, Karen; Zlobec, Inti; Gertler, Ralf; Sisic, Leila; Büchler, Markus; Lordick, Florian; Slotta-Huspenina, Julia; Weichert, Wilko; Höfler, Heinz; Feith, Marcus; Ott, Katja (2014). A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy. Annals of surgical oncology, 21(3), pp. 915-921. Springer 10.1245/s10434-013-3410-y

Slotta-Huspenina, Julia; Becker, Karl-Friedrich; Feith, Marcus; Walch, Axel; Langer, Rupert (2014). Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus. Cancers, 6(3), pp. 1382-1393. MDPI AG 10.3390/cancers6031382

Aichler, Michaela; Elsner, Mareike; Ludyga, Natalie; Feuchtinger, Annette; Zangen, Verena; Maier, Stefan K.; Balluff, Benjamin; Schöne, Cédrik; Hierber, Ludwig; Braselmann, Herbert; Meding, Stephan; Rauser, Sandra; Zischka, Hans; Aubele, Michaela; Schmitt, Manfred; Feith, Marcus; Hauck, Stefanie M; Ueffing, Marius; Langer, Rupert; Kuster, Bernhard; ... (2013). Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. Journal of pathology, 230(4), pp. 410-419. Wiley 10.1002/path.4199

Bettstetter, Marcus; Berezowska, Sabina; Keller, Gisela; Walch, Axel; Feuchtinger, Annette; Slotta-Huspenina, Julia; Feith, Marcus; Drecoll, Enken; Höfler, Heinz; Langer, Rupert (2013). Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome. Human pathology, 44(5), pp. 829-36. Philadelphia, Pa.: Elsevier 10.1016/j.humpath.2012.08.005

Slotta-Huspenina, Julia; Berg, Daniela; Bauer, Karina; Wolff, Claudia; Malinowsky, Katharina; Bauer, Lukas; Drecoll, Enken; Bettstetter, Marcus; Feith, Marcus; Walch, Axel; Höfler, Heinz; Becker, Karl-Friedrich; Langer, Rupert (2012). Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas. PLoS ONE, 7(7), e41420. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0041420

Elsner, Mareike; Rauser, Sandra; Maier, Stefan; Schöne, Cédrik; Balluff, Benjamin; Meding, Stephan; Jung, Gerhard; Nipp, Martin; Sarioglu, Hakan; Maccarrone, Giuseppina; Aichler, Michaela; Feuchtinger, Annette; Langer, Rupert; Jütting, Uta; Feith, Marcus; Küster, Bernhard; Ueffing, Marius; Zitzelsberger, Horst; Höfler, Heinz and Walch, Axel (2012). MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. Journal of proteomics, 75(15), pp. 4693-704. Amsterdam: Elsevier 10.1016/j.jprot.2012.02.012

Meding, Stephan; Nitsche, Ulrich; Balluff, Benjamin; Elsner, Mareike; Rauser, Sandra; Schöne, Cédrik; Nipp, Martin; Maak, Matthias; Feith, Marcus; Ebert, Matthias P; Friess, Helmut; Langer, Rupert; Höfler, Heinz; Zitzelsberger, Horst; Rosenberg, Robert; Walch, Axel (2012). Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. Journal of proteome research, 11(3), pp. 1996-2003. Washington, D.C.: American Chemical Society 10.1021/pr200784p

This list was generated on Sat Dec 21 19:34:14 2024 CET.
Provide Feedback